Table 3.
Radiological assessment of BA, HG, and HGR between the groups.
| Test (n = 14) | Control (n = 14) | Total (n = 28) | |
|---|---|---|---|
| BA (mean ± SD) (mm) | 2.91 ± 0.75 | 2.76 ± 0.62 | 2.83 ± 0.68 |
| p-value | 0.570 | ||
| HG (mean ± SD) (mm) | 2.44 ± 0.75 | 2.27 ± 0.63 | 2.35 ± 0.68 |
| p-value | 0.536 | ||
| BR (mean ± SD) (mm) | 0.47 ± 0.47 | 0.49 ± 0.40 | 0.48 ± 0.43 |
| p-value | 0.511 | ||
| HGR (mean ± SD) (%) | 84.25 ± 14.19 | 82.56 ± 13.04 | 83.41 ± 13.40 |
| p-value | 0.482 | ||
SD, standard deviation; BA, bone augmentation immediately after surgery; HG, hard tissue gain after 6 months of healing; BR, bone graft reduction (BA-HG); HGR, percentage of HG compared with BA (HG/BA); Test group, 3D-PFTM + cross-linked collagen membrane used; Control group, 3D-PFTM + non-cross-linked collagen membrane used.